Fortrea Holdings
Fortrea Holdings Inc is an American contract research organization providing clinical development services to the global biopharmaceutical industry. The company offers phase one through four clinical trial management, patient recruitment, clinical pharmacology, biostatistics, and regulatory consulting services. Revenue is principally generated through fee-for-service research contracts and clinical trial execution agreements with drug developers. Core end markets serve multinational pharmaceutical corporations, biotechnology startups, and medical device developers globally. Fortrea holds a market-leading position as one of the largest standalone global contract research organizations following its spin-off from Labcorp. The company is headquartered in Durham, North Carolina, and its common stock trades on the Nasdaq Global Select Market.
8 of the funds FundTelligence covers report a position in Fortrea Holdings.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 8
Funds holding Fortrea Holdings
- Nordea US High Yield Sustainable Stars Bond Fund — Nordea Funds · 0.53 % (full portfolio disclosed, September 2026)
- Nordea US High Yield Bond — Nordea Funds · 0.49 % (full portfolio disclosed, September 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.2 % (full portfolio disclosed, October 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.19 % (full portfolio disclosed, September 2026)
- Alfred Berg Global High Yield — Alfred Berg · 0.15 % (full portfolio disclosed, June 2026)
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.13 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.02 % (full portfolio disclosed, September 2026)
- Nordea Internationale aktier — Nordea Funds · 0.01 % (full portfolio disclosed, September 2026)